PEOPLE
All aspects of the SURECAN programme have been designed and developed by experts in public health, oncology, psychological impact of cancer, clinical trials and health service research, and has been reviewed and approved by independent reviewers on behalf of the funder (National Institute for Health Research (NIHR) Programme Grants for Applied Research). The SURECAN team includes academics and clinicians, as well as strong patient and public involvement (PI) who have and will inform all aspects of the project design, conduct and outputs.
RESEARCH TEAM
Professor Stephanie Taylor
Professor of Primary Care.
Co-Chief investigator
Queen Mary University of London
Professor Trudie Chalder
Professor of Cognitive Behavioural Psychotherapy.
Co-Chief investigator
King's College London
Mr Imran Khan
Programme Manager
Queen Mary University of London
Dr Sheila Donovan
Qualitative Researcher
Queen Mary University of London
Dr Dipesh Gopal
Primary Care Academic Clinical fellow
Queen Mary University of London
Ms Louise Goodwin
Cancer Research Nurse
Sheffield Teaching Hospitals
Dr Clare Robinson
Senior Trial Statistician
Queen Mary University of London
Dr Francisco J. Gonzalez Carreras
Trial Statistician
Queen Mary University of London
CO-INVESTIGATORS
Dr Adrienne Morgan
PPI representative Independent Cancer Patients' Voice
Dr Gail Eva
Senior Lecturer
Oxford Brookes University
Professor John Gribben
Centre Lead
Centre for Haemato-Oncology
Queen Mary University of London & Barts NHS Trust
Mr Mohamed Thaha
Honorary Consultant in Colorectal Surgery. Principal Investigator at Barts Health Queen Mary University of London & Barts NHS Trust
Professor Ania Korzun
Professor of Psychiatry and Education
Queen Mary University of London
Ms Miriam Harris
PPI representative
Mr Moise Roche
Doctoral researcher in BME populations with Alzheimer’s University College London
Mr Derek Rosario
Consultant Urologist. Principal Investigator for Sheffield Teaching Hospitals
University of Sheffield
Professor Peter White
Emeritus Professor of Psychological Medicine. Original Chief Investigator
Queen Mary University of London
Dr Rebecca Roylance
Consultant Medical Oncologist.Principal Investigator for UCLH,
University College London Hospitals NHS Foundation Trust
Ms Ellie Herrington
Barts Health NHS Trust Patient Public Representative, Chair Barts Bowel Cancer Survivor Group
Barts Health NHS Trust